Adaptive Biotechnologies CorporationADPTNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
4.93
↓ 89% below average
Average (7y)
43.74
Historical baseline
Range
High:110.51
Low:4.15
CAGR
-35.9%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 4.93 | +18.7% |
| 2023 | 4.15 | -29.3% |
| 2022 | 5.88 | -77.0% |
| 2021 | 25.52 | -67.6% |
| 2020 | 78.86 | +80.3% |
| 2019 | 43.73 | -42.7% |
| 2018 | 76.33 | -30.9% |
| 2017 | 110.51 | - |